[1]王 瑜.布地奈德混悬液联合特布他林治疗小儿哮喘的效果[J].医学信息,2022,35(12):184-186.[doi:10.3969/j.issn.1006-1959.2022.12.047]
 WANG Yu.Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma[J].Medical Information,2022,35(12):184-186.[doi:10.3969/j.issn.1006-1959.2022.12.047]
点击复制

布地奈德混悬液联合特布他林治疗小儿哮喘的效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年12期
页码:
184-186
栏目:
药物与临床
出版日期:
2022-06-15

文章信息/Info

Title:
Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma
文章编号:
1006-1959(2022)12-0184-03
作者:
王 瑜
(天津医科大学总医院儿科,天津 300052)
Author(s):
WANG Yu
(Department of Pediatrics,General Hospital of Tianjin Medical University,Tianjin 300052,China)
关键词:
小儿哮喘布地奈德特布他林肺功能炎症反应
Keywords:
Pediatric asthmaBudesonideTerbutalineLung functionInflammatory response
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2022.12.047
文献标志码:
A
摘要:
目的 研究布地奈德混悬液联合特布他林治疗小儿哮喘的临床效果。方法 选取2019年6月-2021年6月天津医科大学总医院儿科收治的84例哮喘患儿,采用随机数字表法分为对照组和观察组,每组42例。对照组给予特布他林治疗,观察组给予布地奈德混悬液联合特布他林治,比较两组临床疗效、肺功能[用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、FEV1占预计值百分比(FEV1%)、呼气一氧化氮(FeNO)]、嗜酸性粒细胞(EOS)、免疫球蛋白E(IgE)、不良反应及预后情况。结果 观察组治疗有效率为97.62%,高于对照组的88.10%(P<0.05);观察组FVC、FEV1、FEV1%高于对照组,FeNO低于对照组(P<0.05);观察组EOS、IgE水平低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);观察组哮喘发作频率低于对照组,发作持续时间短于对照组(P<0.05)。结论 布地奈德混悬液联合特布他林治疗小儿哮喘效果确切,有助于改善患儿肺功能,降低炎性表达,改善预后发作情况,且不增加药物不良反应发生几率。
Abstract:
Objective To study the clinical effect of budesonide suspension combined with terbutaline in the treatment of asthma in children.Methods A total of 84 children with asthma admitted to Department of Pediatrics, General Hospital of Tianjin Medical University from June 2019 to June 2021 were selected and randomly divided into control group and observation group, with 42 cases in each group. The control group was treated with terbutaline, and the observation group was treated with budesonide suspension combined with terbutaline. The clinical efficacy, pulmonary function [forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), FEV1 percentage (FEV1%), expiratory nitric oxide (FeNO)], eosinophils (EOS), immunoglobulin E (IgE), adverse reactions and prognosis of the two groups were compared.Results The effective rate in the observation group was 97.62%, which was higher than 88.10% in the control group (P<0.05). FVC, FEV1 and FEV1% in the observation group were higher than those in the control group, and FeNO was lower than that in the control group (P<0.05). EOS and IgE levels in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). The frequency of asthma attack in the observation group was lower than that in the control group, and the duration of asthma attack was shorter than that in the control group (P<0.05).Conclusion Budesonide suspension combined with terbutaline is effective in the treatment of asthma in children, which is helpful to improve lung function, reduce inflammatory expression, improve prognosis, and does not increase the incidence of adverse drug reactions.

参考文献/References:

[1]周燕,吴新,冯伟,等.小儿咳喘灵口服液辅助治疗小儿哮喘临床疗效观察[J].中国妇幼健康研究,2021,32(7):1020-1024.[2]林忠响.雾化吸入特布他林和布地奈德联合服用小儿咳喘灵颗粒治疗小儿哮喘的临床效果研究[J].中国基层医药,2017,24(5):710-713. [3]刘伟峰,赵春玲,田继红,等.小剂量布地奈德联合孟鲁司特治疗小儿支气管哮喘的效果及安全性分析[J].河南医学研究,2017,26(16):2941-2943. [4]Yoshihara S,Kanno N,Fukuda H,et al.Caregiver treatment satisfaction is improved together with children’s asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms[J].Allergology International,2015,64(4):371-376.[5]高伟霞,秦小菀,刘阳,等.布地奈德联合孟鲁司特治疗小儿哮喘对抗凝血酶Ⅲ、CD5抗原蛋白和NLRP3炎症小体的影响[J].广东医学,2020,41(15):1558-1561.[6]闫鲜鹏,严晓华,任琳娟,等.孟鲁司特钠联合布地奈德治疗89例儿童哮喘的临床研究[J].空军医学杂志,2018,34(3):192-195.[7]中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181.[8]张迪.布地奈德对感染诱发哮喘急性发作患儿趋化素样因子-1水平及免疫功能的影响研究[J]. 贵州医药,2021,45(10):1623-1624.[9]马莉娟,周瑞,王娴娴,等.布地奈德混悬液联合孟鲁司特钠治疗儿童胸闷变异性哮喘的效果分析[J]. 中华全科医学,2020,18(6):899-901,905.[10]石丰月,马平均.布地奈德联合特布他林治疗小儿哮喘的疗效与安全性评价[J].中国合理用药探索,2019,16(3):16-18. [11]Rajanandh MG,Nageswari AD,Ilango K.Assessment of Montelukast,Doxofylline, and Tiotropium With Budesonide for the Treatment of Asthma:Which Is the Best Among the Second-line Treatment? A Randomized Trial[J].Clinical Therapeutics,2015,37(2):418-426. [12]高伟霞,秦小菀,张靖,等.孟鲁司特钠联合普米克令舒治疗小儿哮喘及对抗凝血酶Ⅲ、CD5抗原样蛋白、补体C3、外周血嗜酸粒细胞的影响[J].中国临床医生杂志,2019,47(2):234-236.[13]潘东怡.孟鲁司特钠对小儿哮喘的临床效果及不良反应发生率分析[J]. 黑龙江中医药,2021,50(3):160-161.[14]邹艳萍,罗小兰,刘利.布地奈德与丙酸倍氯米松辅助特布他林雾化吸入治疗小儿哮喘急性发作的对比研究[J].中国药房,2016,27(17):2388-2390,2391. [15]陈美,沈华琴.布地奈德联合特布他林治疗小儿哮喘急性发作的疗效及对肺功能的影响研究[J].山西医药杂志,2021,50(7):1089-1091.[16]汪红艳.布地奈德联合孟鲁司特钠治疗小儿哮喘对抗凝血酶Ⅲ、CD5抗原蛋白和NLRP3炎症小体的影响分析[J].湖北科技学院学报(医学版),2021,35(5):425-427.[17]黎建云,许文博,刘美荣,等.氧驱动雾化吸入疗法在小儿哮喘治疗中的应用效果[J].实用临床医药杂志,2019,23(3):109-111.[18]吴玉丽,赵晓莉,王游.阿奇霉素、β2受体兴奋剂联合糖皮质激素吸入治疗支原体感染引发小儿哮喘的临床效果研究[J].临床和实验医学杂志,2016,15(19):1880-1883. [19]郝玉萍,刘小红.布地奈德混悬液联合特布他林用于小儿哮喘的治疗的效果分析[J].检验医学与临床,2020,17(14):2004-2006,2010.[20]丁臻博,鲁萍,黄永坤,等.孟鲁司特钠与西替利嗪联合布地奈德治疗儿童咳嗽变异性哮喘临床效果、肺功能及安全性[J].昆明医科大学学报,2020,41(3):86-90.

相似文献/References:

[1]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
 MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Medical Information,2018,31(12):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[2]尹静华.孟鲁司特钠治疗小儿哮喘的临床有效性分析[J].医学信息,2018,31(09):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
 YIN Jing-hua.Clinical Efficacy of Montelukast Sodium in Children with Asthma[J].Medical Information,2018,31(12):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
[3]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
 LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Medical Information,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[4]邱亚双.辛夷鼻炎丸联合布地奈德治疗变应性鼻炎的临床观察[J].医学信息,2019,32(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
 QIU Ya-shuang.Clinical Observation of Xinyi Biyan Wan Combined with Budesonide in Treating Allergic Rhinitis[J].Medical Information,2019,32(12):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
[5]王 雪,章 晔,李宝华.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效[J].医学信息,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
 WANG Xue,ZHANG Ye,LI Bao-hua.Clinical Effect of Montelukast Sodium Tablets Combined with Ipratropine Bromide and Budesonide Mixed Suspension Atomization Inhalation on Children with Respiratory Tract Infection Cough[J].Medical Information,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
[6]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,32(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
 ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Medical Information,2019,32(12):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[7]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
 WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,32(12):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[8]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,32(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
 LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[9]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
 GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Medical Information,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
[10]聂 志.吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用[J].医学信息,2019,32(22):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
 NIE Zhi.Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD[J].Medical Information,2019,32(12):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
[11]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
 ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Medical Information,2018,31(12):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[12]周冬娟.布地奈德联合西替利嗪治疗小儿哮喘对患儿呼吸功能及免疫功能指标的影响[J].医学信息,2022,35(03):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]
 ZHOU Dong-juan.Effects of Budesonide Combined with Cetirizine on Respiratory Function andImmune Function in Children with Asthma[J].Medical Information,2022,35(12):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]

更新日期/Last Update: 1900-01-01